Diabetic Macular Edema (DME) Active Not Recruiting Phase 4 Trials for Ranibizumab (DB01270)

Also known as: Diabetic Macular Edema(DME) / Diabetic Macular Oedema / Macular Edema, Diabetic / Diabetic Macular Edema / Diabetic retinal oedema / Diabetic retinal edema

IndicationStatusPhase
DBCOND0060562 (Diabetic Macular Edema (DME))Active Not Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03759860Laser (Selective Retina Therapy) and Drug Combined Intervention in Clinically Significant Diabetic Macular EdemaTreatment